scispace - formally typeset
D

Daniel Wojdyla

Researcher at Duke University

Publications -  161
Citations -  16128

Daniel Wojdyla is an academic researcher from Duke University. The author has contributed to research in topics: Atrial fibrillation & Warfarin. The author has an hindex of 45, co-authored 137 publications receiving 14421 citations. Previous affiliations of Daniel Wojdyla include University of Edinburgh & Memorial Sloan Kettering Cancer Center.

Papers
More filters
Journal ArticleDOI

WHO analysis of causes of maternal death: a systematic review

TL;DR: Haemorrhage and hypertensive disorders are major contributors to maternal deaths in developing countries and these data should inform evidence-based reproductive health-care policies and programmes at regional and national levels.
Journal ArticleDOI

The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity

TL;DR: Developing countries, especially those in Africa and southern Asia, incur the highest burden in terms of absolute numbers, although a high rate is also observed in North America.
Journal Article

The Worldwide Incidence of Preterm Birth: A Systematic Review of Maternal Mortality and morbidity/Incidence Mondiale De la Missance Avant Terme: Revue Sytemtique De la Mortalite et De la Morbidite maternelle/Incidencia Mundial De Parto Prematuro: Revision Sistematica De la Morbilidad Y Mortalidad Maternas

TL;DR: Preterm birth, defined as childbirth occurring at less than 37 completed weeks or 259 days of gestation, is a major determinant of neonatal mortality and morbidity and has long-term adverse consequences for health as mentioned in this paper.
Journal ArticleDOI

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

TL;DR: Dose adjustment in ROCKET-AF yielded results consistent with the overall trial in comparison with dose-adjusted warfarin, and there was no evidence of heterogeneity in treatment effect across dosing groups.